VVUS/ARNA - Qnexa mid dose drop out rate is 11.5% compared to placebo's 8.5 %. Also the mid dose exhibits a lot more efficacy than does lorcaserin's 10mg dosed daily. See slide 20 for drop outs http://www.vivus.com/images/stories/downloads_newsroom/ash-presentation.pdf